Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Oct. 10, 2018. Seema Verma.

Executive Summary

The US Centers for Medicare and Medicaid Services is enacting reforms to open up and potentially speed up the coverage decision processes for new devices and therapies used by local Medicare contractors. See what CMS Administrator Seema Verma said about it here.

"The Trump administration is committed to strengthening Medicare and bringing the latest medical technologies to beneficiaries, and we cannot allow outdated processes and administrative barriers to stand in the way of this." –Seema Verma, administrator, US Centers for Medicare and Medicaid Services

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123406

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel